Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Overview
The report on the isothermal nucleic acid amplification technology (INAAT) market presents a global scale study. It provides insights into the factors favoring the development of novel applications of nucleic acid in nanoparticle diagnostics, molecular diagnostics, and laboratory research. It is compiled with the intent of highlighting the prevailing dynamics and growth opportunities in the global isothermal nucleic acid amplification technology market. Information thus included in the report will help stakeholders get a better perspective of the market.
By the standards of the World Health Organization (WHO), an ideal RNA/DNA diagnostic test kit, which usually includes polymerase chain reaction (PCR) instruments, should be accurate, cost-effective, and customization to cater to specific user requirements. Furthermore, it is necessary for the diagnostic test kits to be less complicated and tough at the same time. All in all, the demand for instruments providing quick and precise results of diagnosis is considerably high.
Given the aforementioned requirements, despite providing practical solutions, the currently available nucleic acid diagnostic technology is unable to fulfil the low-cost requirements and thus fails to achieve any organization’s assurance. The advent of non-PCR technology such as INAAT is thus gaining traction from the research community as it complies with all criteria specific by the WHO. With a little tinkering in the parameters, INAAT can be customized to suit different measurement requirements, thereby facilitating Point-of-Care testing (POCT), while operating within economic standards set by the WHO.
The report studies the growth trajectory of the global INAAT market between 2016 and 2024. The growth drivers and restraints influencing the market over the course of the forecast period. The impact of the latest government policies and the prevalent socio-economic conditions in the overall market is also gauged. It studies the effect of Porter’s five forces in the global INAAT market considering the bargaining power of suppliers and buyers, prevailing degree of competition, and threat of substitute and new entrants.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Drivers and Restraints
In the global isothermal nucleic acid amplification technology market, growth witnessed in the molecular diagnostics segment in the healthcare industry, has emerged as a key driver. The molecular diagnostic market comprises INAAT and PCR. Of these, the INAAT based on type include helicase dependent application (HAD), loop-mediated isothermal amplification (LAMP), strand displacement amplification (SDA), nucleic acid sequence based amplification (NASBA), transcription mediated amplification (TMA), and single primer isothermal amplification (SPIA).
Despite witnessing positive opportunities worldwide, lack of awareness about the advanced diagnostics, especially in underdeveloped economies is acting as a major restraint for the market. It is due to the same factor, that manufacturers are unable to capitalize on the high unmet medical needs in underdeveloped countries. Furthermore, stringent regulations imposed by organizations such as the WHO and certain reluctance to replace the existing PCR solutions with advanced methods in developing nations is posing threat to the global isothermal nucleic acid amplification technology market.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Regional Outlook
Regionally, North America, Asia Pacific, Europe, and Rest of the World (RoW) are the key segments in the global INAAT market. The growth witnessed in the market is majorly driven by the rising demand across the emerging economies in the Middle East and North America (MENA, Asia Pacific, and Rest of the World. The increasing investment in the healthcare industry and the rising awareness about low-cost and effective diagnosis will boost the global INAAT market.
The report presents insights into the growth drivers and restraints impacting the market’s growth across the key regional segments. It also identifies the threats and opportunities prevalent in the regional market, to help companies operating therein gain stronghold.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Vendor Landscape
To study the vendor landscape, the report includes profiles of companies such as bioMerieux, Sharp Corp., Sony Corp., Panasonic, Toshiba Corp., Rohm, PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies, BD Diagnostics, Meridian Bioscience, Eiken Chemical Co. Ltd., Qiagen, Alere, and BioHelix and Quidel.
The presence of large number of companies has rendered the market’s competitive landscape highly competitive. However, manufacturers in this market can expect high dividends by leveraging strategic decisions through collaborations and tie-ups, licensing, and agreements with research institutes with regards to the development of novel INAAT platforms. Furthermore, the manufacturers can gain from acquisition and other marketing strategies aimed at strengthening their position.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.